Literature DB >> 2314485

Endothelium-dependent relaxant action of platelet activating factor in the rat mesenteric artery.

Y Chiba1, N Mikoda, H Kawasaki, K Ito.   

Abstract

Vasorelaxant action of platelet activating factor (PAF) was examined in perfused mesenteric vascular beds and mesenteric artery strips isolated from rats. PAF caused a dose-dependent vasodilation of norepinephrine-contracted mesenteric vascular bed, which was sensitive to CV-3988, a PAF antagonist, but insensitive to tetrodotoxin, atropine, propranolol and indomethacin. PAF also caused a relaxation of phenylephrine-contracted mesenteric artery strips at above 3 X 10(-12) M. Much higher concentrations of PAF were required to relax the aorta, carotid and pulmonary arteries. The PAF- and acetylcholine (ACh)-induced relaxations of mesenteric artery were dependent on the presence of endothelium and were inhibited by either hydroquinone and methylene blue, which inhibit the action of endothelium-derived relaxing factor (EDRF), or L-canavanine, which inhibits the formation of nitric oxide from L-arginine. Phospholipase A2 inhibitors such as quinacrine and ONO-RS-082 abolished the relaxation induced by ACh but did not affect that by PAF. Thus, PAF induces a vasorelaxation by releasing EDRF from endothelial cells as ACh does, although the pathway to produce the substances by PAF may be different from that by ACh.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2314485     DOI: 10.1007/bf00195060

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  8 in total

1.  Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.

Authors:  R J Gryglewski; S Moncada; R M Palmer
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

2.  Endothelium-dependent vasodilation by melittin: are lipoxygenase products involved?

Authors:  U Förstermann; B Neufang
Journal:  Am J Physiol       Date:  1985-07

3.  Activation of phospholipases A and C in human platelets exposed to epinephrine: role of glycoproteins IIb/IIIa and dual role of epinephrine.

Authors:  H S Banga; E R Simons; L F Brass; S E Rittenhouse
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  The nature of endothelium-derived vascular relaxant factor.

Authors:  T M Griffith; D H Edwards; M J Lewis; A C Newby; A H Henderson
Journal:  Nature       Date:  1984 Apr 12-18       Impact factor: 49.962

5.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.

Authors:  R F Furchgott; J V Zawadzki
Journal:  Nature       Date:  1980-11-27       Impact factor: 49.962

6.  Vascular endothelial cells synthesize nitric oxide from L-arginine.

Authors:  R M Palmer; D S Ashton; S Moncada
Journal:  Nature       Date:  1988-06-16       Impact factor: 49.962

7.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

Review 8.  Endothelial cells as mediators of vasodilation of arteries.

Authors:  R F Furchgott; P D Cherry; J V Zawadzki; D Jothianandan
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

  8 in total
  7 in total

1.  Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.

Authors:  H Moritoki; T Hisayama; S Takeuchi; H Miyano; W Kondoh
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

2.  Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats.

Authors:  Y Tanaka; S Hayakawa; T Imai; A Akutsu; H Hirano; H Tanaka; T Nakahara; K Ishii; K Shigenobu
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

3.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.

Authors:  K Noguchi; T Matsuzaki; N Shiroma; Y Ojiri; M Sakanashi
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

5.  Role of R-type calcium channels in the response of the perfused arterial and venous mesenteric vasculature of the rat to platelet-activating factor.

Authors:  A Claing; G Bkaily; N Berthiaume; P Sirois; M Rola-Pleszczynski; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

6.  Quinidine, but not eicosanoid antagonists or dexamethasone, protect the gut from platelet activating factor-induced vasoconstriction, edema and paralysis.

Authors:  Ingmar Lautenschläger; Inéz Frerichs; Heike Dombrowsky; Jürgen Sarau; Torsten Goldmann; Karina Zitta; Martin Albrecht; Norbert Weiler; Stefan Uhlig
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Platelet-activating factor (PAF) strongly enhances contractile mechanical activities in guinea pig and mouse urinary bladder.

Authors:  Ge Liu; Mizuki Kaneko; Kento Yoshioka; Keisuke Obara; Yoshio Tanaka
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.